The number of diabetes patients reportedly exceeded 6 million in 2020. Considering the pre-diabetic population amounts to about 15.83 million, more than 20 million Koreans suffer from diabetes or the risk of diabetes, according to the Korea Diabetes Association (KDA).On the other hand, only 9.7 perc
The drug regulator ordered Korea Pharma to suspend manufacturing of medicines including steroid cream, saying the drugmaker violated the Good Manufacturing Practices (GMP). On Aug. 30, the Ministry of Food and Drug Safety ordered Korea Pharma’s manufacturing suspension due to the company’s violation
LG Chem is accelerating efforts to develop a new gout treatment.The company recently submitted applications for phase 3 investigational new drug (IND) clinical trials to the Chinese regulator, following the U.S., drawing attention to its future development process.In a public notice on Monday, LG Ch
HLB said that it signed an 18.5 billion won ($13.4 million) supply contract with Abbott, a U.S.-based multinational healthcare company, to supply sterile foam swabs.The agreement follows a previous supply contract to provide 14.5 billion won worth of sterile foam swabs to Abbott in March.HLB entered
Korea is almost the only country that recorded an increase in excess deaths during the Omicron wave due to its problematic critical care system bent only on making makeshift responses, an expert pointed out.Professor Kim Young-sam of the Department of Pulmonology at Severance Hospital made these and
Bridge Biotherapeutics said that it signed a cooperation agreement with Brainomix, a U.K.-based artificial intelligence (AI) medtech firm, to efficiently conduct phase 2 clinical trials of BBT-877, an idiopathic pulmonary fibrosis (IPF) treatment candidate.Under the accord, Bridge Biotherapeutics wi
“The message given to us is clear. We shortened the vaccine development period from 10 years to two years, but we have to reduce it to 100 days. This is impossible with traditional methods and technology. We need innovative frameworks and technology.”So said Chey Chang-won, vice president of SK Disc
An analyst said SK Biopharmaceuticals needs to expand its product portfolio not only just with new drugs developed in-house but also by licensing in new candidate substances from outside for the company to grow."I expect SK Biopharmaceuticals will be able to secure a stable cash flow until 2032, whe
The Korean health authorities decided to curb or suspend operations of temporary Covid-19 screening sites across the nation, as the strong typhoon Hinnamnor was expected to land in the southern coast of the peninsula on Tuesday morning.According to the Korea Disease Control and Prevention Agency (KC
Lunit said that it plans to present five abstracts highlighting the efficacy of Lunit SCOPE, its artificial intelligence (AI)-biomarker platform, during the European Society for Medical Oncology (ESMO) Congress 2022 in Paris from Sep. 9 to 13.The upcoming event is expected to draw more than 25,000 o
Radiotherapy has emerged as a new alternative treatment for liver cancer patients difficult to treat with the operation.A joint team of four professors at two medical departments in Samsung Medical Center unveiled their results based on the analysis of the “SMC liver cancer registry” on Monday. Prof
Helixmith has made public the topline data of the phase 2a clinical trial of Engensis (VM202), its genetic treatment candidate for amyotrophic lateral sclerosis (ALS).In a public notice last Friday, Helixmith said it had received the topline data of phase 2a trials of VM202 on patients from its cont
HLB’s investigational anticancer drug, rivoceranib, proved the safety as a second-line treatment in gastric cancer in a phase 1 trial, according to an abstract partially released before the annual meeting of the European Society for Medical Oncology this Friday.The abstract includes results from a K
Vuno, a medical tech startup, has transferred its artificial intelligence-based voice recognition business to Puzzle AI, drawing attention from industry watchers on its background.Last Friday, Vuno signed a transfer contract with Puzzle AI, announcing it handed over all assets, tangible and intangib
Despite Korean biopharmaceutical companies’ sales growth by 20 percent on-year in the first half, their stock prices plunged, resulting in a significant loss in their market capitalizations.According to the Electronic Disclosure System of the Korea Exchange, the total sales of the top 25 biopharmace
Korea’s second monkeypox patient contacted 15 people after arriving at Incheon International Airport from Europe on Aug. 19, raising concerns over loopholes in the nation’s monkeypox screening system. According to the Korea Disease Control and Prevention Agency (KDCA), the patient tested positive fo
The government has started delivering the first batch of SkyCovione, SK Bioscience's Covid-19 vaccine, to local governments across the country, and requested that the recipients participate in the inoculation.The delivery of the first batch follows a research conducted by the National Institute of I
The one-year grace period granted to Kolon TissueGene has ended. The securities authorities suspended the company’s stock transaction over the past year due to controversy over unwarranted ingredient change in Invossa, the world’s first osteoarthritis cell genetic treatment.In a public notice on Wed
Dongwha Pharmaceutical said it joined hands with Animuscure, a Korean biotech startup, to co-develop a sarcopenia treatment.Under the accord, the two companies will conduct joint research to identify and develop innovative candidates for the new synthetic drug treatment for muscle disease that Dongw
The five-year survival rate of breast cancer in Korea is 86.6 percent, higher than that of the Organisation for Economic Co-operation and Development (OECD) average at 84.5 percent.However, the five-year relative survival rate when diagnosed with advanced or metastatic breast cancer is only 30 perce